Recent News

• 04.14.2025 - Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
• 04.14.2025 - Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
• 02.07.2025 - Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.07.2025 - Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
• 01.31.2025 - Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
• 01.31.2025 - Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
• 01.31.2025 - Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025

Recent Filings

• 03.18.2025 - 3 Initial statement of beneficial ownership of securities
• 03.10.2025 - 8-K Current report
• 02.19.2025 - EFFECT Notice of Effectiveness
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - 8-K Current report
• 02.14.2025 - CORRESP Correspondence
• 02.12.2025 - UPLOAD SEC-generated letter
• 02.07.2025 - 8-K Current report
• 02.07.2025 - S-3 Registration statement under Securities Act of 1933
• 02.07.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]